nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—BDKRB2—malignant glioma	0.063	0.0673	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—KNG1—malignant glioma	0.0573	0.0613	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—malignant glioma	0.0439	0.0469	CbGpPWpGaD
Azilsartan medoxomil—Telmisartan—PPARG—malignant glioma	0.0401	0.627	CrCbGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—GDNF—malignant glioma	0.0333	0.0356	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL12A—malignant glioma	0.0304	0.0325	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CCR4—malignant glioma	0.0286	0.0305	CbGpPWpGaD
Azilsartan medoxomil—Candesartan—PTGS1—malignant glioma	0.0239	0.373	CrCbGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-C—malignant glioma	0.0225	0.024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CXCR3—malignant glioma	0.0212	0.0227	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Arf6 signaling events—MET—malignant glioma	0.0211	0.0226	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PTK2—malignant glioma	0.0206	0.022	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Arf6 signaling events—EGF—malignant glioma	0.0197	0.021	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—BDKRB2—malignant glioma	0.0194	0.0208	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL12B—malignant glioma	0.0191	0.0204	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—malignant glioma	0.0156	0.0167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—malignant glioma	0.0156	0.0167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PTPN11—malignant glioma	0.0147	0.0157	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR4—malignant glioma	0.0134	0.0144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—PDGFRA—malignant glioma	0.0134	0.0143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-B—malignant glioma	0.0133	0.0142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—malignant glioma	0.0133	0.0142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FGF2—malignant glioma	0.0126	0.0135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-A—malignant glioma	0.0123	0.0132	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Arf6 signaling events—EGFR—malignant glioma	0.0107	0.0114	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.0105	0.0112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CD80—malignant glioma	0.0104	0.0111	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCR3—malignant glioma	0.00999	0.0107	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—BDKRB2—malignant glioma	0.00926	0.00989	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—BDKRB2—malignant glioma	0.00914	0.00976	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00902	0.00963	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—KNG1—malignant glioma	0.00842	0.009	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—KNG1—malignant glioma	0.00832	0.00888	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00828	0.00884	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IFNG—malignant glioma	0.00822	0.00878	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00782	0.00836	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—malignant glioma	0.00767	0.00819	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CXCL8—malignant glioma	0.00764	0.00816	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00753	0.00805	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1B—malignant glioma	0.00733	0.00783	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CASP3—malignant glioma	0.00731	0.00781	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL2—malignant glioma	0.0073	0.0078	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00716	0.00764	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—malignant glioma	0.00699	0.00747	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR4—malignant glioma	0.00687	0.00734	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.0067	0.00716	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00667	0.00713	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—VEGFA—malignant glioma	0.00621	0.00663	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00613	0.00655	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LATS2—malignant glioma	0.00587	0.00627	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—malignant glioma	0.00571	0.0061	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00558	0.00596	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—F2—malignant glioma	0.00544	0.00582	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—F2—malignant glioma	0.00537	0.00574	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—malignant glioma	0.00532	0.00568	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCR3—malignant glioma	0.0051	0.00545	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.00487	0.0052	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—BDKRB2—malignant glioma	0.00467	0.00499	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.00458	0.00489	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LATS1—malignant glioma	0.00445	0.00475	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—KNG1—malignant glioma	0.00425	0.00454	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR4—malignant glioma	0.00388	0.00415	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.00379	0.00405	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.00366	0.00391	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.0036	0.00385	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR4—malignant glioma	0.00352	0.00377	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MDK—malignant glioma	0.003	0.00321	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCR3—malignant glioma	0.00288	0.00308	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DTX1—malignant glioma	0.00287	0.00306	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—F2—malignant glioma	0.00275	0.00293	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—BDKRB2—malignant glioma	0.00264	0.00282	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCR3—malignant glioma	0.00262	0.0028	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00254	0.00271	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.00251	0.00268	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.00243	0.0026	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—KNG1—malignant glioma	0.0024	0.00256	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—BDKRB2—malignant glioma	0.0024	0.00256	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.00237	0.00253	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SUFU—malignant glioma	0.00228	0.00243	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HEY2—malignant glioma	0.00225	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GFAP—malignant glioma	0.0022	0.00235	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—KNG1—malignant glioma	0.00218	0.00233	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.00218	0.00232	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SPHK1—malignant glioma	0.00213	0.00227	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HEY1—malignant glioma	0.00208	0.00222	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR4—malignant glioma	0.00208	0.00222	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HIST1H3B—malignant glioma	0.00202	0.00216	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL8—malignant glioma	0.00193	0.00207	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—MMP3—malignant glioma	0.00193	0.00206	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—JAG2—malignant glioma	0.00185	0.00197	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—H3F3A—malignant glioma	0.00156	0.00167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—F2—malignant glioma	0.00155	0.00166	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCR3—malignant glioma	0.00155	0.00165	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—YWHAE—malignant glioma	0.00151	0.00161	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK2—malignant glioma	0.00151	0.00161	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FLT1—malignant glioma	0.0015	0.0016	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—DUSP6—malignant glioma	0.00149	0.00159	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CG—malignant glioma	0.00148	0.00159	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—JAG1—malignant glioma	0.00147	0.00157	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOTCH3—malignant glioma	0.00147	0.00157	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FBXW7—malignant glioma	0.00144	0.00154	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BDKRB2—malignant glioma	0.00142	0.00151	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—F2—malignant glioma	0.00141	0.00151	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT2—malignant glioma	0.00136	0.00145	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CG—malignant glioma	0.00135	0.00144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PTPN11—malignant glioma	0.00132	0.00142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOTCH2—malignant glioma	0.00132	0.00141	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CD—malignant glioma	0.00131	0.00139	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KNG1—malignant glioma	0.00129	0.00138	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT2—malignant glioma	0.00123	0.00132	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK1—malignant glioma	0.00123	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CD—malignant glioma	0.00119	0.00127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP3—malignant glioma	0.00114	0.00122	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CB—malignant glioma	0.00114	0.00122	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CDKN2B—malignant glioma	0.00113	0.00121	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTK2—malignant glioma	0.0011	0.00117	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL8—malignant glioma	0.00109	0.00117	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HES1—malignant glioma	0.00108	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NCOR1—malignant glioma	0.00107	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—RAF1—malignant glioma	0.00106	0.00113	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2—malignant glioma	0.00104	0.00112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CB—malignant glioma	0.00103	0.0011	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDGFRA—malignant glioma	0.00103	0.0011	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SPP1—malignant glioma	0.000997	0.00107	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL8—malignant glioma	0.000993	0.00106	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2—malignant glioma	0.000949	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TERT—malignant glioma	0.000945	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDGFB—malignant glioma	0.000923	0.000986	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FGFR1—malignant glioma	0.000918	0.000981	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HIF1A—malignant glioma	0.000904	0.000966	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CAV1—malignant glioma	0.000874	0.000934	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KDR—malignant glioma	0.000865	0.000924	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—F2—malignant glioma	0.000832	0.000889	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FN1—malignant glioma	0.000832	0.000889	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BAD—malignant glioma	0.000822	0.000879	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOTCH1—malignant glioma	0.000814	0.00087	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CD80—malignant glioma	0.000798	0.000852	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APC—malignant glioma	0.000796	0.000851	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CG—malignant glioma	0.000796	0.000851	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EGF—malignant glioma	0.000787	0.000841	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTPN11—malignant glioma	0.000782	0.000836	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BRAF—malignant glioma	0.000749	0.0008	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT2—malignant glioma	0.000729	0.000778	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—EGFR—malignant glioma	0.000726	0.000775	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CD—malignant glioma	0.0007	0.000748	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000693	0.000741	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—KRAS—malignant glioma	0.000685	0.000732	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FGF2—malignant glioma	0.00067	0.000716	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PIK3CA—malignant glioma	0.00063	0.000673	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MDM2—malignant glioma	0.000627	0.00067	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RAF1—malignant glioma	0.000625	0.000668	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ERBB2—malignant glioma	0.000618	0.000661	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CB—malignant glioma	0.00061	0.000652	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL8—malignant glioma	0.000586	0.000626	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AKT1—malignant glioma	0.000567	0.000605	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CASP3—malignant glioma	0.000561	0.0006	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2—malignant glioma	0.00056	0.000599	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP9—malignant glioma	0.00053	0.000567	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTEN—malignant glioma	0.000527	0.000563	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AKT1—malignant glioma	0.000514	0.00055	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VEGFA—malignant glioma	0.000476	0.000509	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STAT3—malignant glioma	0.000472	0.000504	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MYC—malignant glioma	0.000438	0.000468	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EGFR—malignant glioma	0.000429	0.000458	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KRAS—malignant glioma	0.000405	0.000433	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PIK3CA—malignant glioma	0.000372	0.000397	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TP53—malignant glioma	0.00036	0.000384	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AKT1—malignant glioma	0.000304	0.000325	CbGpPWpGaD
